{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:10:18Z","timestamp":1793859018248,"version":"4.6.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.surg.2023.07.003","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T08:07:06Z","timestamp":1691482026000},"page":"836-843","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Imaging lymph node regression can predict the pathological tumor regression grade in gastric cancer after neoadjuvant treatment"],"prefix":"10.1016","volume":"174","author":[{"given":"Feiyu","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenglin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4299-1327","authenticated-orcid":false,"given":"Jingyu","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2023.07.003_bib1","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s10120-019-00956-6","article-title":"Recurrence after preoperative chemotherapy and surgery for gastric adenocarcinoma: a multicenter study","volume":"22","author":"Mokadem","year":"2019","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.surg.2023.07.003_bib2","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1245\/s10434-017-5838-y","article-title":"Patterns of Initial Recurrence in Gastric Adenocarcinoma in the Era of Preoperative Therapy","volume":"24","author":"Ikoma","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2023.07.003_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer","volume":"355","author":"Cunningham","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.surg.2023.07.003_bib4","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1200\/JCO.2010.33.0597","article-title":"Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial","volume":"29","author":"Ychou","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.surg.2023.07.003_bib5","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/S1470-2045(16)30531-9","volume":"17","author":"Al-Batran","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.surg.2023.07.003_bib6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/COC.0000000000000058","article-title":"Phase II study of neoadjuvant chemotherapy with S-1 and CDDP in patients with lymph node metastatic stage II or III gastric cancer","volume":"40","author":"Kochi","year":"2017","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.surg.2023.07.003_bib7","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4251\/wjgo.v7.i12.389","article-title":"Neo-adjuvant chemo(radio)therapy in gastric cancer: Current status and future perspectives","volume":"7","author":"Biondi","year":"2015","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.surg.2023.07.003_bib8","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1200\/JCO.2014.55.9070","article-title":"Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction","volume":"32","author":"Davies","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.surg.2023.07.003_bib9","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1200\/JCO.2015.65.7692","article-title":"Effect of pathologic tumor response and nodal status on survival in the medical research council adjuvant gastric infusional chemotherapy trial","volume":"34","author":"Smyth","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.surg.2023.07.003_bib10","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.6004\/jnccn.2016.0137","article-title":"Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology","volume":"14","author":"Ajani","year":"2016","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.surg.2023.07.003_bib11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4251\/wjgo.v12.i1.37","article-title":"Interpretation of the development of neoadjuvant therapy for gastric cancer based on the vicissitudes of the NCCN guidelines","volume":"12","author":"Wang","year":"2020","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.surg.2023.07.003_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/SLA.0000000000002672","article-title":"Is a Pathological complete response following neoadjuvant chemoradiation associated with prolonged survival in patients with pancreatic cancer?","volume":"268","author":"He","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2023.07.003_bib13","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/SLA.0000000000002719","article-title":"Prognostic implications of pathological response to neoadjuvant chemoradiation in pathologic stage III rectal cancer","volume":"269","author":"Karagkounis","year":"2019","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2023.07.003_bib14","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1002\/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C","article-title":"Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations","volume":"73","author":"Mandard","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.surg.2023.07.003_bib15","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00000658-199903000-00001","article-title":"Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer","volume":"229","author":"Lowy","year":"1999","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2023.07.003_bib16","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/bjc.2016.252","article-title":"Role of histological regression grade after two neoadjuvant approaches with or without radiotherapy in locally advanced gastric cancer","volume":"115","author":"Martin-Romano","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1016\/j.surg.2023.07.003_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.153073","article-title":"Connection and distinction of tumor regression grading systems of gastrointestinal cancer","volume":"216","author":"Tong","year":"2020","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.surg.2023.07.003_bib18","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41379-019-0393-7","article-title":"Varying practices in tumor regression grading of gastrointestinal carcinomas after neoadjuvant therapy: results of an international survey","volume":"33","author":"Westerhoff","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.surg.2023.07.003_bib19","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/SLA.0b013e318216f449","article-title":"Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas: a summary of 480 cases","volume":"253","author":"Becker","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2023.07.003_bib20","first-page":"2495","article-title":"[New response evaluation criteria in solid tumours-revised RECIST guideline (version 1.1)]","volume":"36","author":"Watanabe","year":"2009","journal-title":"Gan To Kagaku Ryoho"},{"key":"10.1016\/j.surg.2023.07.003_bib21","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1200\/JCO.2003.06.574","article-title":"Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: results of a prospective trial","volume":"21","author":"Ott","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.surg.2023.07.003_bib22","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.surg.2023.07.003_bib23","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/cjp2.169","article-title":"Significance of tumour regression in lymph node metastases of gastric and gastro-oesophageal junction adenocarcinomas","volume":"6","author":"Reim","year":"2020","journal-title":"J\u00a0Pathol Clin Res"},{"key":"10.1016\/j.surg.2023.07.003_bib24","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ejca.2008.10.028","article-title":"Evaluation of lymph nodes with RECIST 1.1","volume":"45","author":"Schwartz","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.surg.2023.07.003_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10120-016-0622-4","article-title":"Japanese gastric cancer treatment guidelines 2014 (ver. 4)","volume":"20","year":"2017","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.surg.2023.07.003_bib26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10120-011-0041-5","article-title":"Japanese classification of gastric carcinoma: 3rd English edition","volume":"14","year":"2011","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.surg.2023.07.003_bib27","series-title":"Protocol for the Examination of Specimens From Patients With Carcinoma of the Stomach","author":"Chanjuan Shi","year":"2020"},{"key":"10.1016\/j.surg.2023.07.003_bib28","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1177\/1066896919869477","article-title":"Pathological tumor regression grade classifications in gastrointestinal cancers: role on patients' prognosis","volume":"27","author":"Fanelli","year":"2019","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.surg.2023.07.003_bib29","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.4251\/wjgo.v13.i12.2161","article-title":"Comparison of tumor regression grading systems for locally advanced gastric adenocarcinoma after neoadjuvant chemotherapy","volume":"13","author":"Liu","year":"2021","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.surg.2023.07.003_bib30","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1186\/1477-7819-12-397","article-title":"Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy","volume":"12","author":"Sun","year":"2014","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.surg.2023.07.003_bib31","first-page":"6465","article-title":"CA724 predicts tumor regression grade in locally advanced gastric cancer patients with neoadjuvant chemotherapy","volume":"12","author":"Tong","year":"2021","journal-title":"J\u00a0Cancer"},{"key":"10.1016\/j.surg.2023.07.003_bib32","article-title":"Prediction model of tumor regression grade for advanced gastric cancer after preoperative chemotherapy","volume":"11","author":"Xu","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.surg.2023.07.003_bib33","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1007\/s00432-018-2728-z","article-title":"Locally advanced gastric cancer: total iodine uptake to predict the response of primary lesion to neoadjuvant chemotherapy","volume":"144","author":"Gao","year":"2018","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.surg.2023.07.003_bib34","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1200\/JCO.2005.02.2574","article-title":"Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma","volume":"24","author":"Motzer","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.surg.2023.07.003_bib35","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1245\/s10434-011-2165-6","article-title":"Posttherapy nodal status, not graded histologic response, predicts survival after neoadjuvant chemotherapy for advanced gastric cancer","volume":"19","author":"Fujitani","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2023.07.003_bib36","first-page":"369","article-title":"Gastric cancer: correlation between clinicopathological factors and survival of patients (III)","volume":"50","author":"Laz\u0103r","year":"2009","journal-title":"Rom J Morphol Embryol"},{"key":"10.1016\/j.surg.2023.07.003_bib37","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/jso.22085","article-title":"Clinicopathologic variables predicting tumor response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer","volume":"105","author":"Wang","year":"2012","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.surg.2023.07.003_bib38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","article-title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial","volume":"398","author":"Janjigian","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.surg.2023.07.003_bib39","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41575-022-00703-w","article-title":"Current developments in gastric cancer: from molecular profiling to treatment strategy","volume":"20","author":"Alsina","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.surg.2023.07.003_bib40","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx095","article-title":"Tumor regression grading after preoperative chemoradiotherapy as a prognostic factor and individual-level surrogate for disease-free survival in rectal cancer","volume":"109","author":"Fokas","year":"2017","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.surg.2023.07.003_bib41","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.ejso.2018.02.004","article-title":"Surgical morbidity and mortality after neoadjuvant chemotherapy in the CRITICS gastric cancer trial","volume":"44","author":"Claassen","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.surg.2023.07.003_bib42","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1245\/s10434-010-1388-2","article-title":"Preoperative chemotherapy with cisplatin and docetaxel followed by surgery and clip-oriented postoperative chemoradiation in patients with localized gastric or gastroesophageal junction adenocarcinoma: results from a phase II feasibility study","volume":"18","author":"Spizzo","year":"2011","journal-title":"Ann Surg Oncol"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606023004300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606023004300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:08:14Z","timestamp":1758539294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606023004300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0039606023004300"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2023.07.003","relation":{},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imaging lymph node regression can predict the pathological tumor regression grade in gastric cancer after neoadjuvant treatment","name":"articletitle","label":"Article Title"},{"value":"Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surg.2023.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}